Concepedia

Author

Chiara Saggia

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Also Known As

C Saggia, C. Saggia, Chiara Saggia, Lorenzo Chiudinelli, Tondulli, Luca

42

Publications

574

Citations

9

H-Index

16

Concepts

All Affiliations

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”Azienda Ospedaliero Universitaria Maggiore della CaritaAzienda Sanitaria di FirenzeAzienda Ospedaliera Santa Maria Degli AngeliIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
CS

About

Chiara Saggia is an author at Università degli Studi del Piemonte Orientale “Amedeo Avogadro” specializing in medicine, breast cancer, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

118

2

Health Sciences

1

1

28

3

Epidemiology

1

1

10

4

Neurology

1

1

19

5

Pathology

1

1

19

Chiara Saggia

×

7

Publications

182

Citations

7

H-Index

YearCitations

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: A multi-institutional retrospective analysis

Marina Chiara Garassino, Valter Torri, G. Michetti,

Lung Cancer

2010

61

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life

Ornella Garrone, Filippo Montemurro, Chiara Saggia,

SpringerPlus

2016

39

Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT

Gianluca Bottoni, Arnoldo Piccardo, Francesco Fiz,

European Journal of Radiology

2021

28

Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients

Chiara Pizzamiglio, Paolo Ripellino, Paolo Prandi,

Neurophysiologie Clinique

2020

19

Side Effects Associated with Ultrarapid Cytochrome P450 2D6 Genotype among Women with Early Stage Breast Cancer Treated with Tamoxifen

Roberta Rolla, Matteo Vidali, S. Meola,

Clinical Laboratory

2012

13

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

Stefania Gori, Alessandro Inno, Elena Fiorio,

PLoS ONE

2015

12

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study

Sara Gagno, Mario D’Andrea, Mauro Mansutti,

Clinical Breast Cancer

2018

10

Page 1